echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Protein genomics reveals markers of chemotherapy resistance and prognosis in triple-negative breast cancer

    Protein genomics reveals markers of chemotherapy resistance and prognosis in triple-negative breast cancer

    • Last Update: 2022-09-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Researchers at Baylor College of Medicine, the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard, as well as Washington University in St.


    "TNBC is one of the most difficult types of breast cancer to treat, and standard treatments require multiple chemotherapy drugs and unfortunately often fail to cure patients," said


    The research team used an innovative analytical method, and they previously developed a method called microscale protein genomics to analyze tumor biopsies


    "Proteomic analysis of pretreated biopsies uniquely reveals metabolic pathways associated with treating drug resistance, including fatty acid metabolism," Anurag said


    The team then analyzed


    "In other cancer types, the loss of LIG1 has also been associated with a poor prognosis, suggesting that this deletion has broader clinical implications," Anurag said


    This groundbreaking study clearly reveals the power of combining microscopic protein genome analysis with careful clinical research to generate new insights


    The protein product of LIG1 is an important part


    "This is an exciting result that demonstrates a very close collaboration between patients, oncology care teams and lab scientists," said



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.